The day 14 conundrum still remains unresolved!

Author:

Malhotra Hemant,Soni Priyanka,Gupta Naveen

Publisher

Medknow

Subject

General Medicine

Reference8 articles.

1. The utility of day 14 bone marrow response assessment in patients undergoing acute myeloid leukemia induction: A single institution retrospective experience;Manuprasad;Cancer Res Stat Treat,2021

2. Impact of day 14 bone marrow biopsy on re-induction decisions and prediction of a complete response in acute myeloid leukemia cases;Alsaleh;Asian Pac J Cancer Prev,2018

3. Does day 14 bone marrow status predict response to chemotherapy in acute myeloid leukemia.Experience of a hemato-oncology care center from Eastern India?;Nataraj;Clin Cancer Investig J,2020

4. Futility of day 14 bone marrow in acute myeloid leukemia on 3+7 induction – Is it time to bid adieu to day 14 bone marrow?;Mirgh;Cancer Res Stat Treat,2021

5. Outcomes and impact of Minimal Residual Disease (MRD) in pediatric, Adolescent And Young Adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol;Pandey;Cancer Res Stat Treat,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Authors' reply to Chaudhary et al. and Soni et al.;Cancer Research, Statistics, and Treatment;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3